Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Vaccitech Plc (VACC)
NASDAQ:VACC
Holding VACC?
Track your performance easily
VACC Stock Chart & Stats
Day’s Range$4.28 - $5.1
52-Week Range― - ―
Previous Close$4.49
Volume165.35K
Average Volume (3M)N/A
Market Cap
$157.95M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next Earnings
Nov 09, 2023EPS Estimate
-$0.53Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$7.42Price Target Upside48.40% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
Vaccitech Plc News
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
0.07% Other Institutional Investors
99.93% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
VACC FAQ
What was Vaccitech Plc’s price range in the past 12 months?
Currently, no data Available
What is Vaccitech Plc’s market cap?
Currently, no data Available
When is Vaccitech Plc’s upcoming earnings report date?
Vaccitech Plc’s upcoming earnings report date is Nov 09, 2023 which is 408 days ago.
How were Vaccitech Plc’s earnings last quarter?
Vaccitech Plc released its earnings results on Aug 10, 2023. The company reported -$0.62 earnings per share for the quarter, missing the consensus estimate of -$0.546 by -$0.074.
Is Vaccitech Plc overvalued?
According to Wall Street analysts Vaccitech Plc’s price is currently Undervalued.
Does Vaccitech Plc pay dividends?
Vaccitech Plc does not currently pay dividends.
What is Vaccitech Plc’s EPS estimate?
Vaccitech Plc’s EPS estimate is -$0.53.
How many shares outstanding does Vaccitech Plc have?
Currently, no data Available
What happened to Vaccitech Plc’s price movement after its last earnings report?
Vaccitech Plc reported an EPS of -$0.62 in its last earnings report, missing expectations of -$0.546. Following the earnings report the stock price went down -0.455%.
Which hedge fund is a major shareholder of Vaccitech Plc?
Currently, no hedge funds are holding shares in VACC
---
Vaccitech Plc Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$7.42 (48.40% Upside)
$7.42 (48.40% Upside)
Blogger Sentiment
Bullish
VACC Sentiment 100%
Sector Average 69%
Sector Average 69%
Technicals
SMA
Positive
20 days / 200 days
Momentum
24.24%
12-Months-Change
Fundamentals
Return on Equity
-23.49%
Trailing 12-Months
Asset Growth
-13.66%
Trailing 12-Months
Company Description
Vaccitech Plc
Vaccitech PLC is a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer. Its therapeutic programs include VTP-300, VTP-200, VTP-850, and VTP-600. Its current prophylactic programs include VTP-400. In addition, it also co-invented a COVID-19 vaccine candidate with the University of Oxford known as COVID-19 Vaccine AstraZeneca.
---
VACC Stock 12 Month Forecast
Average Price Target
$7.42
▲(48.40% Upside)
Technical Analysis
Best Analysts Covering VACC
1 Year
1 Year Success Rate
5/17 ratings generated profit
1 Year Average Return
-24.79%
reiterated a buy rating 2 years ago
Copying Yi Chen's trades and holding each position for 1 Year would result in 29.41% of your transactions generating a profit, with an average return of -24.79% per trade.
---